Spago Nanomedical AB (OSTO:SPAGO) 3-Year Book Growth Rate : -64.10% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB 3-Year Book Growth Rate?

Spago Nanomedical AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr0.15.

During the past 12 months, Spago Nanomedical AB's average Book Value per Share Growth Rate was -92.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -64.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -43.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was -20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Spago Nanomedical AB was -2.70% per year. The lowest was -64.10% per year. And the median was -10.15% per year.

Competitive Comparison of Spago Nanomedical AB's 3-Year Book Growth Rate

For the Biotechnology subindustry, Spago Nanomedical AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spago Nanomedical AB's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's 3-Year Book Growth Rate falls into.

Spago Nanomedical AB 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Spago Nanomedical AB (OSTO:SPAGO) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Spago Nanomedical AB 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Spago Nanomedical AB (OSTO:SPAGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

7UX:Germany

Address

Scheelevagen 22, Lund, SWE, SE-223 63

Website

https://www.spagonanomedical.se

Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (OSTO:SPAGO) Headlines

No Headlines